Authors: WANDEL C KIM RB KAJIJI S GUENGERICH FP WOOD AJJ

Citation: C. Wandel et al., EFFECTS OF P-GLYCOPROTEIN (P-GP) INHIBITORS ON CYP3A, Clinical pharmacology and therapeutics, 63(2), 1998, p.

Authors: TANGWAI DF KAJIJI S DICAPUA F DEGRAAF D RONINSON IB GROS P

Citation: Df. Tangwai et al., HUMAN (MDR1) AND MOUSE (MDR1,MDR3) P-GLYCOPROTEINS CAN BE DISTINGUISHED BY THEIR RESPECTIVE DRUG-RESISTANCE PROFILES AND SENSITIVITY TO MODULATORS, Biochemistry, 34(1), 1995, pp. 32-39

Authors: HAUSKE JR KAJIJI S DORFF P JULIN S DIBRINO J PAILLET S

Citation: Jr. Hauske et al., INVESTIGATION OF THE EFFECTS OF SYNTHETIC, NONCYTOTOXIC IMMUNOPHILIN INHIBITORS ON MDR, Bioorganic & medicinal chemistry letters, 4(17), 1994, pp. 2097-2102

Authors: KAJIJI S DRESLIN JA GRIZZUTI K GROS P

Citation: S. Kajiji et al., STRUCTURALLY DISTINCT MDR MODULATORS SHOW SPECIFIC PATTERNS OF REVERSAL AGAINST P-GLYCOPROTEINS BEARING UNIQUE MUTATIONS AT SERINE(939 941)/, Biochemistry, 33(17), 1994, pp. 5041-5048

Authors: DHIR R GRIZZUTI K KAJIJI S GROS P

Citation: R. Dhir et al., MODULATORY EFFECTS ON SUBSTRATE-SPECIFICITY OF INDEPENDENT MUTATIONS AT THE SERINE(939 941) POSITION IN PREDICTED TRANSMEMBRANE DOMAIN-11 OF P-GLYCOPROTEINS/, Biochemistry, 32(36), 1993, pp. 9492-9499

Authors: KAJIJI S TALBOT F GRIZZUTI K VANDYKEPHILLIPS V AGRESTI M SAFA AR GROS P

Citation: S. Kajiji et al., FUNCTIONAL-ANALYSIS OF P-GLYCOPROTEIN MUTANTS IDENTIFIES PREDICTED TRANSMEMBRANE DOMAIN-11 AS A PUTATIVE DRUG-BINDING SITE, Biochemistry, 32(16), 1993, pp. 4185-4194